Inventory

Components of inventory, net of reserves as of March 31, 2020 and December 31, 2019 are as follows:



	March 31, 2020		December 31, 2019
Raw Materials	$	2,750,185	$	2,471,234
Work in Process	291,697		184,382
Finished Goods	1,873,886		1,432,290
Total	$	4,915,768	$	4,087,906

As of March 31, 2020, we classified $0.6 million of inventory as non-current, all of which was related to Triferic or the active pharmaceutical ingredient and raw materials for Triferic. As of March 31, 2020, we had total Triferic inventory aggregating $3.4 million, against which we had reserved $2.4 million.

The $1.0 million net value of Triferic inventory consisted of $0.2 million of Triferic Dialysate finished goods with expiration dates ranging from June 2020 to May 2021, $0.5 million of Triferic API with estimated remaining shelf life extending through 2023, and $0.3 million of raw materials for Triferic with estimated remaining shelf life extending beyond 2025.